Sanofi to enroll thousands for its coronavirus vaccine trials

PARIS: French drugmaker Sanofi SA said it plans to enroll thousands of subjects globally for trials of an experimental vaccine for the coronavirus it is developing with GlaxoSmithKline Plc, and that it has started to discuss advanced purchases with several countries. Sanofi is working on two vaccine projects to prevent COVID-19 -- the illness caused by the new coronavirus -- and said it is exploring several manufacturing options, including fresh collaborations to ensure it can meet demand, if either program is successful. Drugmakers are rushing to develop treatments and vaccines for the highly contagious coronavirus that has killed over 255,000 people worldwide, infected more than 3.6...